MGO One Seven LLC Purchases Shares of 24,760 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

MGO One Seven LLC bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 24,760 shares of the pharmacy operator's stock, valued at approximately $231,000.

Other large investors have also recently made changes to their positions in the company. Norges Bank purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $58,241,000. Invesco Ltd. grew its position in shares of Walgreens Boots Alliance by 8.8% during the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after acquiring an additional 2,631,332 shares during the period. Vanguard Group Inc. grew its holdings in Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after purchasing an additional 2,279,495 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock worth $122,737,000 after acquiring an additional 2,185,950 shares during the last quarter. Finally, Amundi raised its position in shares of Walgreens Boots Alliance by 70.3% in the fourth quarter. Amundi now owns 4,455,720 shares of the pharmacy operator's stock valued at $41,082,000 after purchasing an additional 1,839,045 shares during the period. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Up 0.5 %

Shares of WBA traded up $0.05 on Friday, reaching $10.98. The stock had a trading volume of 7,844,424 shares, compared to its average volume of 21,044,179. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The firm has a market capitalization of $9.49 billion, a price-to-earnings ratio of -1.07, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a 50-day simple moving average of $10.98 and a 200-day simple moving average of $10.26.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. During the same period in the previous year, the firm posted $1.20 EPS. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on WBA. Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. StockNews.com began coverage on shares of Walgreens Boots Alliance in a report on Sunday, April 27th. They issued a "hold" rating on the stock. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Finally, Truist Financial lowered their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $10.59.

Insiders Place Their Bets

In related news, Chairman Stefano Pessina purchased 832,258 shares of the company's stock in a transaction dated Sunday, April 27th. The shares were purchased at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the acquisition, the chairman now directly owns 145,621,079 shares in the company, valued at $1,603,288,079.79. The trade was a 0.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.